Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.9M Buy
+106,500
New +$12M ﹤0.01% 3437
2023
Q1
Sell
-797,700
Closed -$87.6M 5562
2022
Q4
$87.6M Sell
797,700
-292,100
-27% -$30.2M ﹤0.01% 2084
2022
Q3
$105M Buy
1,089,800
+764,200
+235% +$81.5M ﹤0.01% 1920
2022
Q2
$35.4M Buy
+325,600
New +$37M ﹤0.01% 2727
2015
Q3
Sell
-100,000
Closed -$4.91M 3203
2015
Q2
$4.91M Buy
+100,000
New +$4.8M 0.01% 854

Other funds holding ABT

BlackRock's ABT Position: Q1 2026 in Review

BlackRock reduced its Abbott (ABT) stake by 0.83% in Q1 2026, selling an estimated $138M and leaving 145,687,458 shares worth $15B. The position accounts for 0.26% of the portfolio, ranked #59.

BlackRock first reported a position in ABT in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.3B in Q4 2021. 3,089 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • BlackRock held 145,687,458 shares of Abbott worth $15B as of Q1 2026.
  • BlackRock sold 1,221,310 Abbott shares in Q1 2026, an estimated $138M.
  • Abbott made up 0.26% of BlackRock's portfolio in Q1 2026, its #59 holding.
  • BlackRock first reported a position in Abbott in Q2 2013 and has held it in 52 quarters since.
  • BlackRock's Abbott position peaked at $19.3B in Q4 2021.
  • 3,089 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.